Adriamycin 2 mg/mL (Doxorubicin Hydrochloride INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 2 mg/mL

Adriamycin 2 mg/mL is a lyophilized powder for solution, used primarily in chemotherapy. This intravenous injection, containing Doxorubicin Hydrochloride, is manufactured by Hikma Pharmaceuticals USA Inc.

Strength

2 mg/mL

Pack Size

1 VIAL in 1 BOX (0143-9275-01) / 5 mL in 1 VIAL

Manufacturer / TM Owner

Hikma Pharmaceuticals USA Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Adriamycin 2 mg/mL is generally used in cancer treatment protocols. Doxorubicin Hydrochloride, the active ingredient, is often part of chemotherapy regimens. Patients and healthcare providers commonly seek information on what Adriamycin is used for, particularly in managing various types of cancer.

Side Effects

Adriamycin 2 mg/mL may cause common effects such as nausea, fatigue, and hair loss. These effects can vary among individuals and are typically managed under medical supervision. Patients are advised to discuss potential effects with their healthcare provider.

Precautions & Warnings

Handling Adriamycin 2 mg/mL requires careful attention to safety protocols. The powder should be reconstituted and administered as directed by a healthcare professional. Proper storage and disposal are essential to ensure safety.

Avoid Interactions

Adriamycin 2 mg/mL may interact with other medications, including certain chemotherapy drugs and supplements. Patients should inform their healthcare provider about all medications they are taking to avoid potential interactions. Alcohol and other substances may also affect the efficacy and safety of Adriamycin.

Frequently Asked Questions

Adriamycin 2 mg/mL is primarily used in chemotherapy for cancer treatment. It is often part of regimens for various types of cancer.

Adriamycin 2 mg/mL is administered intravenously after reconstitution. A healthcare professional should handle the preparation and administration.

Common effects may include nausea, fatigue, and hair loss. These effects can vary among individuals and should be discussed with a healthcare provider.

Yes, Adriamycin 2 mg/mL may interact with other medications, including certain chemotherapy drugs and supplements. Patients should inform their healthcare provider about all medications they are taking.

Adriamycin 2 mg/mL should be stored as directed by the manufacturer and healthcare provider. Proper storage is essential to maintain the drug's efficacy and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.